Dotmatics

Thank you to everyone who attended our Discover Dotmatics event in San Diego yesterday, and a special thank you to Fernando Garces from BioGlyph for his presentation on “Breaking Barrierd in MsAb Innovation”. We had a great evening meeting with our users and sharing insights on Luma! For more information on our solutions, visit our website: https://lnkd.in/eZMTnht2 Philip Mounteney Andrew LeBeau Melanie Nelson John Kressman

Watch our latest on-demand webinar "Rethinking Flow Cytometry: Eliminating Manual Data Handling with the Luma and OMIQ Integration " Presented by Philip Mounteney and Julia Prier, PhD. Discover how the Luma + Omiq integration is addressing the challenges in flow cytometry, and view real-time demonstrations of each solution workflow! Watch now: https://lnkd.in/epaNVu2F

The Luma Antibody & Protein Engineering Solution is the first in our series of custom-built, multimodal solutions powered by the Luma platform! Built to streamline antibody discovery and development, this new solution integrates industry-leading tools like Geneious and GraphPad Prism for seamless R&D workflows. Designed for biologics, it bridges bench science with in-silico innovation, making complex therapeutic research simpler and more connected. “The Luma Antibody & Protein Engineering solution addresses long-standing gaps in the antibody discovery workflow by providing an end-to-end process that seamlessly composes many of scientists’ favorite tools directly into Luma,” - Kalim Sailba, Chief Product Officer at Dotmatics. For more information on this solution, visit our blog: #AntibodyDiscovery #Biologics #Dotmatics #Luma https://lnkd.in/d45iasAY

Dotmatics ELN and Data Discovery Platform enabled BIAL to streamline workflows, improve data access, and significantly reduce IT burden, allowing researchers to focus more on advancing life-changing treatments. Learn more about Bial and the impacts that implementing Dotmatics has made to their team in our latest case study 🖥️ : https://lnkd.in/gST5HjMs

Fierce Biotech featured Dotmatics in their latest article to discuss Dotmatics' innovative Antibody Engineering software platform, designed to accelerate and optimize R&D for life sciences organizations. Read the full article to learn more about how Luma can transform your R&D process! https://lnkd.in/eJ8Nt_nc

Download our latest ebook to discover how Dotmatics' Luma platform supports cutting-edge research by bringing together different scientific disciplines and preparing for an AI-driven future. In this ebook, we review recent trends seen with AI in the pharmaceutical industry and explore how companies can best position themselves to ensure their R&D data are AI-ready. #Luma #DotmaticsLuma #AI Visit our page to download and learn more: https://lnkd.in/erqxq6ww

Introducing the all-in-one Luma Antibody & Protein Engineering solution. Powered by industry-trusted tools like Geneious and GraphPad Prism, this groundbreaking platform is transforming biologics R&D. For More information on this solution, visit our Antibody and Protein Engineering Solution page: https://lnkd.in/eAcH29sa

Dotmatics has been featured on VentureBeat for our announcement on launching Geneious Luma. Geneious Luma accelerates workflows, streamlines data integration, and eliminates silos in biopharma research, helping researchers uncover insights faster and advance therapeutic discovery. Read the full article to explore how Dotmatics is unlocking new possibilities in drug development through cutting-edge AI. https://lnkd.in/eMinPs9W

Join us at our Discover Dotmatics event in San Diego on October 30th and hear from Philip Mounteney of Dotmatics and Fernando Garces, CEO of BioGlyph present 'Breaking Barriers in MsAb Innovation'. In this presentation they will discuss how BioGlyph has developed a universal naming structure integrated with an intuitive graphical interface, which allows scientists to focus on designing optimal MsAb formats for their projects, while the platform handles molecule registration seamlessly in the background. Register now to learn more: https://lnkd.in/eJ9R256V

We are excited to announce the launch of Luma Antibody & Protein Engineering solution, a comprehensive end-to-end solution for streamlining the antibody discovery and development process, with an emphasis on monoclonal and multispecific antibodies. The first of these scientific products seamlessly composed within Luma and being introduced today is Geneious Luma, showcasing cross-therapeutic capabilities within a unified platform For more information, read our press release: https://lnkd.in/ejCWpuZD